ALB and osteosarcoma: All these results translated into an improved antitumor efficacy in an orthotopic osteosarcoma‐xenografted mouse model; the mice in the HSA‐TPP MAP group exhibited a significant reduction in the osteosarcoma volume without showing any noticeable systemic toxicities when compared with those in the solution MAP and HSA MAP groups.